GHK-Cu care map

Weigh a copper peptide offer

What supports the offer?

Look for people, and the same form.

A useful study question is simple: did people with a concern like mine receive the same kind of product?

The human evidence is still thin.

Few studies have tested GHK-Cu in people, and most trials were small and about face creams, according to reviews checked September 30, 2026.

More research is needed to judge what GHK-Cu does in people.

It does leave room to ask how well a particular claim has been tested.

Ask what was measured: a change people could see, a lab result or simply how satisfied they felt.

A small skin trial gave a mixed answer.

Thirteen people completed Miller and colleagues’ 2006 study after laser skin treatment. Some used skincare with GHK-Cu, and others used skincare without it.

Doctors judging the skin did not know who had used GHK-Cu. Their ratings and computer measurements showed no clear difference between the groups in redness, wrinkles or overall skin quality.

People given the GHK-Cu skincare reported greater satisfaction.

It was a small study on skin after laser treatment; its result cannot settle what happens on all skin.

A personal impression and a measured change answer different questions. Ask which kind of result is being claimed.

A cream study cannot answer an injection question.

No trial of GHK-Cu injections in people was found in ClinicalTrials.gov, the U.S. study register, when it was searched September 30, 2026.

This search covered only that study register on that date.

Cell and animal findings do not establish that GHK-Cu injections work in people.

  • Was the tested ingredient actually GHK-Cu?
  • Was it used on skin or injected?
  • What change was measured in people?
  • What uncertainty remains for the concern I have?

A short route to the evidence.

The reviews describe gaps in human testing. The trial report separates measured skin changes from satisfaction.